AB Active ETFs Inc - AB Corporate Bond ETF
EYEG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$208.71M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $208.71 Million |
|---|---|
| Enterprise Value | $203.22 Million |
| Annual dividend | $1.71 |
| Dividend yield | 5.07% |
| Earnings per Share | $-2.64 |
| Beta | 0.21 |
| Outstanding Shares | 6,177,679 |
Return
| Return on Equity | -65.18% |
|---|---|
| Return on Assets | -46.21% |
| Return on Invested Capital | 22.08% |
Valuation & Multiples
| P/E Ratio | -13.5 |
|---|---|
| PEG | 395.65 |
| Price to Sales | - |
| Price to Book Ratio | 16.89 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 43 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 8, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Eyegate Pharmaceuticals Inc
CEO: Stephen From
BUFM actively manages FLEX options in efforts to participate in the price return of the SPDR S&P 500 ETF (SPY), up to a cap, and provide partial downside protection over an outcome period that ranges from 90 to 120 days. In exchange for ...